Search

Author/Creator Ramio-Torrenta, Lluis

1. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial. Issue 3 (21st May 2022)

Authors:
Vermersch, Patrick; Brieva-Ruiz, Luis; Fox, Robert J.; Paul, Friedemann; Ramio-Torrenta, Lluis; Schwab, Matthias; Moussy, Alain; Mansfield, Colin; Hermine, Olivier; Maciejowski, Maciej
Other Names:
author non-byline.; Hecham N. author non-byline.; Deri N. Haydeé author non-byline.; Djelilovic-Vranic J. author non-byline.; Milanov I. author non-byline.; Shotekov P. author non-byline.; Blevins G. author non-byline.; Girard J. author non-byline.; Lapierre Y. author non-byline.; Camu W. author...
Journal:
Neurology
Issue:
Volume 9:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2020)

Authors:
Cree, Bruce A C; Cutter, Gary; Wolinsky, Jerry S; Freedman, Mark S; Comi, Giancarlo; Giovannoni, Gavin; Hartung, Hans-Peter; Arnold, Douglas; Kuhle, Jens; Block, Valerie; Munschauer, Frederick E; Sedel, Frédéric; Lublin, Fred D; Reingold, Stephen; Duquette, Pierre; Derfuss, Tobias; Fazekas, Franz...
Journal:
Lancet neurology
Issue:
Volume 19:Issue 12(2020)
Page Start:
988
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search